Alpha Lipoic Acid for Burning Mouth - BMS Clinical Trials

Alpha Lipoic Acid for Burning Mouth
This study has been completed.
First Received: October 12, 2006 No Changes Posted
Sponsored by: Mayo Clinic
Information provided by: Mayo Clinic
ClinicalTrials.gov Identifier: NCT00387543
Purpose

Discussion and evaluation of patinets with sore and burning mouth to determine whether aplha lipoic acid is helpful in managing their symptoms.

Condition
Burning Sore Mouth

Drug Information available for: Thioctic Acid
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Official Title: Review of Mayo Clinic Experience With Burning Mouth Syndrome - Use of Alpha Lipoic Acid

Further study details as provided by Mayo Clinic:

Estimated Enrollment: 200
Study Start Date: January 2000
Eligibility

Ages Eligible for Study: 1 Year and older
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Criteria

Patients seen in the Department of Dermatology with diagnosis of burning mouth syndrome between 2000 and 2005
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00387543

Locations
United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: Allison J. Bruce Mayo Clinic
More Information

No publications provided

Study ID Numbers: 06-002344
Study First Received: October 12, 2006
Last Updated: October 12, 2006
ClinicalTrials.gov Identifier: NCT00387543 History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Antioxidants
Vitamin B Complex
Vitamins
Trace Elements
Micronutrients
Thioctic Acid
Burning Mouth Syndrome

Additional relevant MeSH terms:
Antioxidants
Vitamin B Complex
Molecular Mechanisms of Pharmacological Action
Growth Substances
Vitamins
Physiological Effects of Drugs
Micronutrients
Protective Agents
Pharmacologic Actions
Thioctic Acid

ClinicalTrials.gov processed this record on April 17, 2009